AN-4005
N/A
Report date: 2026/02/06 20:01:23
NME
Base Information
Drug NameAN-4005
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
Inactive CompaniesXiamen Biotime Biotechnology Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A